Table 3. Frequency distribution of DR4 haplotypes in GBC patients and HC.
Haplotypes | Frequency | p- value | OR (95%CI) | |
HC 246 (%) | GBC 400 (%) | |||
Crs20575Ars20576Grs6557634 | 0.5917 | 0.4316 | --- | Reference |
Crs20575Ars20576Ars6557634 | 0.119 | 0.2095 | <0.0001a | 2.76 (1.71 – 4.47) |
Grs20575Ars20576Grs6557634 | 0.0947 | 0.1427 | 0.0084b | 2.09 (1.21 – 3.62) |
Grs20575Ars20576Ars6557634 | 0.1154 | 0.0737 | 0.62 | 0.86 (0.47 – 1.57) |
Grs20575Crs20576Grs6557634 | 0.0306 | 0.0719 | 0.022c | 2.80 (1.16–6.76) |
Grs20575Crs20576Ars6557634 | 0.0337 | 0.028 | 0.23 | 1.75 (0.71–4.32) |
Crs20575Crs20576Grs6557634 | 0.0127 | 0.0288 | 0.31 | 1.83 (0.57–5.92) |
Global haplotype association p-value: 0.00038d |
HC - Healthy control, GBC - Gallbladder cancer, OR - Odds Ratio, CI - Confidence Interval.
Significant Values are given in bold, FDR pcorr = 0.0005a, 0.0244b, 0.0335c, 0.0015d.